URGN
UroGen Pharma Ltd.
$34.38
-$1.04(-2.94%)
58
Overall
40
Value
75
Tech
60
Quality
Market Cap
$1.71B
Volume
404.02K
52W Range
$6.64 - $32.37
Target Price
$36.88
EPS Estimates Overview
| Current Quarter | $-0.42 | Next Quarter | $-0.16 |
| Current Year | $-0.98 | Next Year | $1.4 |
| QoQ Growth | +61.9% | YoY Growth | +242.9% |
| 3Y EPS CAGR | +12.8% | Target Price | $36.88 |
| Consensus | Buy | Upside | +7.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | URGN | $34.38 | -2.9% | 404.02K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |